CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 495 enrolled
Drug / intervention
WalkAide +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01087957
NCT01087957N/ACompleted
CompareCT.gov

Randomized Trial of the Innovative Neurotronics WalkAide Compared to Conventional Ankle-Foot Orthosis (AFO) in Stroke Patients (INSTRIDE)

Innovative Neurotronics·interventional·Posted Mar 16, 2010·Updated May 13, 2014

In Brief

A clinical study evaluating WalkAide and Ankle-Foot Orthosis (AFO) for Stroke. Completed, enrolled 495 participants across 29 sites.

Detailed Summary

To establish equivalence or incremental benefit to standard of care Ankle-Foot Orthosis (AFO) for patients with foot drop due to stroke, and to assess the functional improvement of ambulation and improved activities of daily living.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedMar 16, 2010
Enrollment StartMar 1, 2010
Primary CompletionFeb 1, 2012
Study CompletionJun 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 16.3 years ago

Interventions

WalkAidedevice

Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)

Ankle-Foot Orthosis (AFO)other

Comparison of WalkAide device against Ankle-Foot Orthosis (AFO)